Sagimet Biosciences Inc. (SGMT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2022: $158.0K2023: $75.14M2024: $75.84M2025: $35.02M$35.02M
2022Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$35.02M-53.8%
2024$75.84M+0.9%
2023$75.14M+47456.3%
2022$158.0K